Hints and tips:
...He said most partners were moving to protect long-term relationships with the biotech industry in the knowledge that the next pandemic could be “right around the corner”....
...In the past, regulators have tended to focus their energies on drugmakers who try to corner the market by buying up lots of medicines that treat the same disease....
...“Thanks to their hard work, we achieved a vaccine in record time and currently have multiple vaccines available — enough to reach every corner of the globe,” said John Murphy, chief policy officer at Bio...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...“No corners have been cut, none at all,” the MHRA’s Dr Raine said on Wednesday. The EMA plans to issue a decision on the BioNTech/Pfizer vaccine at a meeting on December 29, at the latest....
...Daily counts of new cases have since fallen markedly but a third wave is widely feared to be around the corner....
...Both shots are likely to be approved before the end of the year, boosting hopes the world will be able to turn a corner in the battle against coronavirus....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...Vaccines requiring less stringent storage conditions may be around the corner. Moderna’s only needs to be stored at minus 20C....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The EU tensions with Austria have also come as Vienna negotiates with Russia to purchase 1m doses of its Sputnik V vaccine by April....
...Markdoc comments on fears that corners may be cut to rush through the new vaccine in EU to buy up to 300m doses of BioNTech-Pfizer vaccine Any company that rushed a vaccine to market without being certain...
...Among its allegations, greedy pharmaceutical companies were rushing vaccines to market by cutting corners in clinical trials. Scientists and fact-checkers moved quickly to debunk its theories....
...Pfizer's shares are worth $215bn, two-fifths more than the 10 top world airlines, even after news of Pfizer's vaccine breakthrough caused a rally in travel stocks. The outlook is gloomier for banks....
...This doesn’t mean we are in the midst of a V-shaped recovery, however....
...Brunswick Group hired former Pfizer China government affairs vice-president Xi Qing as a partner in Asia....
...Other contenders in the race to develop the first Covid-19 vaccine include GlaxoSmithKline, Sanofi, Pfizer and Boston-based biotech Moderna....
...“The world has turned the corner on tobacco....
...A bigger problem lurks just around the corner for Netflix: the rise of other streaming platforms....
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...In the corner, two grey-haired businessmen are deep in conversation. A woman and a small boy take the table next to ours....
...It did not take long for Pfizer to perform a U-turn....
...You could call it “Cook v Zuck”. In one corner, Tim Cook, the cautious veteran trying to rise above the fray. In the other, Mark Zuckerberg, the embattled upstart with a lot to prove....
...Yes, Apple Watch has a growing selection of the company’s own designs and there is an extensive range of third-party “complications” — the little icons in the corners of the screen that show anything from...
International Edition